chrisvoncsefalvay/vaers-outcomes huggingface dataset:
minor allergic reaction in forearms; they were red; my body was a little bit itchy; left forearm was more redder than the right because that's where I received that vaccination; This is a spontaneous report from a contactable consumer (patient). A 36-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: unknown), via an unspecified route of administration in left arm on 08Jan2021 11:00 at single dose for COVID-19 immunization. No medical history and concomitant medications reported. The facility where the most recent COVID-19 vaccine was administered was in the Nursing Home/Senior Living Facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has been tested for COVID-19, Nasal Swab: negative on 09Jan2021. The patient stated, "I received the shot at 11 am and broke out in a minor allergic reaction in my forearms around 4pm, they were red and my body was a little bit itchy. The left forearm was more redder than the right because that's where I received that vaccination" in Jan2021. The outcome of the events was recovered on unspecified date. The patient took Benadryl as treatment for the events.  Information on the Lot/Batch number has been requested.
Swelling of the armpit and pain on left arm for a week now and since yesterday legs swollen .
severe myocarditis; blood clots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID: (Unknown).  A male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Cancer" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary series completed with unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (DOSE NUMBER UNNOWN (BOOSTER), SINGLE, Unknown manufacturer), for Covid-19 immunization. The following information was reported: MYOCARDITIS (death, medically significant), outcome "fatal", described as "severe myocarditis"; THROMBOSIS (death, medically significant), outcome "fatal", described as "blood clots". The patient date of death was unknown. Reported cause of death: "severe myocarditis", "blood clots". It was not reported if an autopsy was performed. Clinical course: the patient's father in law died of severe myocarditis and blood clots 1 month after receiving his 2nd Pfizer covid booster shot. The patient was a recovered cancer patient who had a perfectly clean bill of health and was just examined prior and had a heart that was in perfect shape.   The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.; Reported Cause(s) of Death: severe myocarditis; blood clots
Around 2 AM I had woke up and had a headache and felt really tired. It followed me for the next 48 hours basically, and then just disappeared. It is exactly how it happened when I had Covid. I had extreme fatigue and lack of energy and a upper sore arm.
Redness, whelps/blisters, warmth swelling at inj site.
Severe headache several hours after injection.  Took tylenol at 3am and it went away.  Headache returned later in the day and for the next 14 days after the vaccination.  Had to take motrin or tylenol every day.
29-year-old female presenting with signs and symptoms suggestive of delayed (1  week) inflammatory reaction to Covid 19 vaccine.  Cellulitis is less likely. Given Benadryl and hydrocortisone cream
Mom Called approx 90 min after vaccine and reported hives beginning at vaccine site and spreading to legs and trunk. TX with Benadryl and Baking soda baths.
Pt received vaccine, took 6 steps, fell to the ground unconscious and had a 60 sec grand mal seizure then regained consciousness.  BP after seizure 60/40 pale clammy skin.  Pt had bit her tongue and had foam around her mouth.  BP raised in 7 mins.  Benadryl at 1500 25mg. 2/25/08-records receivedfor DOS 2/12/08-Impression: Syncopal episode. Presented to ED after experiencing syncopal episode immediately upon injection of vaccine. PE: unremarkable.
About 1.5-2 hours after vaccination, experienced severe lower back pain unlike anything I've had for over a year.  No sudden or extraneous physical efforts were attempted during this time.  Severe muscle spasm felt imminent all night.  Next morning symptoms have slightly subsided.
This spontaneous report as received from a pharmacist refers to a 60 year old female patient with poison ivy. On 16-APR-2014 the patient was vaccinated with ZOSTAVAX, lot # J011335, expiry date 13-DEC-2014, 0.65 ml, subcutaneous. Pharmacist reported the patient had poison ivy, prior to receiving ZOSTAVAX; however, poison ivy worsened. Pharmacist stated that the patient received a betamethasone 30mg injection two days later after receiving ZOSTAVAX vaccination for poison ivy (18-APR-2014). The outcome of poison ivy had worsened was unknown. Additional information has been requested.
Red, swollen, hard, lump "the size of 2 Quarters" no c/o discomfort noted.
There were no adverse events due to the vaccine that I know of. I tested positive for Covid-19 on October 25, 2021 symptoms were cough, headache and congestion that began on October 24, but because my daughter tested positive on October 24 I decided to test right away instead of waiting 5 to 7 days since I had symptoms. I was sick from the 25 through Oct 31 with a headache, congestion and muscle aches, and for a couple days loss of taste then smell. On Nov 1 I only had muscle aches, then on the 3rd all symptoms were gone
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 28-AUG-2014, the patient was vaccinated with an expired dose of PNEUMOVAX 23, 0.5 ml intramuscular, Lot # J009827, expiration date on 10-AUG-2014. No adverse effects were reported. Additional information has been requested.
The covid-19 Bi-Valent Booster was administered to the patient without a written consent form. The immunizing pharmacist traveled to Assisted Living facility to administer both influenza and Covid 19 immunizations. All residents at the facility received both of these vaccinations. After the vaccines were administered, it was brought to our attention that patient only wanted to receive the influenza vaccine and not the Covid vaccine. She received both doses. This event happened roughly 3 hours ago and no adverse events have been witnessed at this time.
Mild itching  began about four-five days after the first shot. Itching became sever and I developed a large red lump, hard and warm to the touch, at the injection site. Symptoms are beginning to clear now on day 10.
This spontaneous report as received from a physician refers to a 66 year old female patient. The patient's medical history included coronary artery disease (reported as CAD) and hypertension (reported as HTN). The patient had no drug reactions/allergies. On 02-JUL-2013 the patient was vaccinated ("probably" according to the reporter) with PNEUMOVAX23, 0.5 ml, intramuscular. Dose number was not reported. The lot number was reported as 8017759 with expiry date 04-JUL-2014 which was confirmed to be non valid. Concomitant therapies included apravastation (not further specified) lisinopril, carvedilol, bupropion hydrochloride, aspirin and albuterol. On 02-JUL-2013 the patient was seen in the emergency room with a 17 cm x 13 cm induration at injection site, swelling of the injection site (disability), pain at the injection site (disability) and fever of 101 F. The pain and swelling had limited the movement of the patient's arm. The physician stated that she had ruled out cellulitis and the she will be discharging the patient from the emergency room with medication to treat the pain. The patient was not hospitalized. The outcome of swollen injection site, painful injection site, fever of 101 F and induration at injection site was reported as not recovered/not resolved. Additional information has been requested.
Patient was given an extra dose of Tdap after receiving a dose 1 month prior. No adverse reactions reported at the time of this report.
Wheezing, swelling lt eyelid; Benadryl administered, prompt response, no S.O.B noted, wheezing abated, swelling diminished. Client responded with wheezing after same vaccines in the past.
Pain at injection site, fatigue, chills, nausea, intermittent and random muscle pain, explosive diarrhea, nausea.
side effect after dose of covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect after dose of covid-19 vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effect after dose of covid-19 vaccine). At the time of the report, VACCINATION COMPLICATION (side effect after dose of covid-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
This spontaneous report as received from a Registered Nurse refers to a unspecified number of patients of unknown gender and unknown age. It was reported that on an unknown date, the unspecified number of patients received unspecified doses of PNEUMOVAX, (dose number, lot/batch number, expiration date, route of administration not reported), that were improperly stored from 20-MAR-2014 to 07-MAY-2014. Nurse stated that vaccines were exposed to 10.5C for 56.05 hours cumulatively (also reported as 15C for more than 59 hours) through 07-MAY-2014. It was reported that also M-M-R II, GARDASIL, ROTATEQ, and PEDVAX were improperly stored (event captured in MARRS#1405USA012894, 1406USA000955, 1406USA000957, and 1406USA000958 respectively). No adverse effects were reported.   Follow-up information has been received from the Registered Nurse. It was reported that the nurse was inquiring about temperature excursions that occurred from October 2013-March 2014 (previously reported as 20-MAR-2014 to 07-MAY-2014). The nurse also stated they were replacing the refrigerator, freezer, and the data logger and were sending the old data logger for calibration to the health department.   Follow-up information has been received from the Registered Nurse on 27-JUN-2014. The reporter stated that on an unknown date one patient received PNEUMOVAX lot # J005067 and exp date 17-JAN-2015 which was stored improperly (highest temperature: 9C, number of hours prior to administration: 36 hours) for a period from 28-AUG-2013 until June 2014 (previously reported as October 2013-March 2014). This is one of several reports from the same reporter.  Additional information is not expected, as correspondence was returned by post office.
Experiencing vertigo; morning sugar is up to 135-140 without eating any sugar; This spontaneous case was reported by a consumer and describes the occurrence of HYPERGLYCAEMIA (morning sugar is up to 135-140 without eating any sugar) and VERTIGO (Experiencing vertigo) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HYPERGLYCAEMIA (morning sugar is up to 135-140 without eating any sugar). In June 2021, the patient experienced VERTIGO (Experiencing vertigo). At the time of the report, HYPERGLYCAEMIA (morning sugar is up to 135-140 without eating any sugar) and VERTIGO (Experiencing vertigo) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Blood glucose increased: 135-140 (High) Morning sugar is up to 135-140 without eating any sugar.         Concomitant product use was not provided by the reporter.  No treatment information was provided.  Patient stated that he did not think that vertigo was related to vaccine but he was not sure.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 06-Aug-2021: Follow-up received contains newevent.
Hives noted in the evening on date of vaccine administration, waxing and waning over the next 4 days, last noted the evening prior to filing this report. Benadryl 2+ doses given for itching. No vomiting, shortness of breath, or wheezing.
Severe pain in arm and shoulder, feels like a fracture.  Unable to move arm without severe pain.
High dose flu shot received at Employee Health at hospital October 18, 2018. Area of injection developed what appeared to be a pustule at injection site within 2 days of injection. Returned to Employee Health November 1, 2018, to have area on right upper arm evaluated. Area of injection site did not heal and continued to get bigger, raised, reddened, painful, and itchy. Three weeks after injection have raised reddened area with pain and itching area of approximately 1 cm by 1 centimeter.  Saw Primary care physician for evaluation. Determined possible cellulitis vs keloid formation at injection site. Prescribed a course of antibiotics then to follow up with Dermatologist at later date for course of treatment.
This spontaneous report as received from a certified medical assistant to a 12 year old patient of an unknown gender. The patients' medical history, concurrent conditions and concomitant medications were not reported. Approximately in 2015 (reported as 27-AUG-2015 to 03-SEP-2015) the patient was vaccinated with improperly stored dose of GARDASIL lot # K010215 with expiration date 05-MAY-2017 or lot # K011562 with expiration date 08-APR-2017; dose and route of administration were not reported). No adverse experiences were reported. This is one of the several reports received from same reporter. Additional information has been requested.
Waited 1/2 hour and left.  On way home, 10 minutes out, throat started to close up.   Took 25 mg of Benadryl and got home. Could talk and breath ok but increasingly difficult to swallow.
3 to 4 days after first and second anthrax vaccinations I had intense itching on thighs, back, stomach, forearms, and buttocks.  I had a red rash on stomach and patches of bumps on buttocks.  Symptoms were less severe after third anthrax vaccination.
Lower back pain; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Lower back pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Lyme disease.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced BACK PAIN (Lower back pain). At the time of the report, BACK PAIN (Lower back pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.  On 09-Mar-2021, the patient reported of having lower back pain. Reportedly, the patient had a prior history of Lymes disease.  No Concomitant product use was reported. No treatment information was provided.
Bad cold/really bad cold on his chest; 37 days since first dose, has not received 2nd yet; This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Bad cold/really bad cold on his chest) and PRODUCT DOSE OMISSION ISSUE (37 days since first dose, has not received 2nd yet) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 088d21a) for COVID-19 vaccination.     Concurrent medical conditions included Diabetes, Cancer and Heart disorder.    On 22-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Sep-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (37 days since first dose, has not received 2nd yet). In October 2021, the patient experienced NASOPHARYNGITIS (Bad cold/really bad cold on his chest). On 22-Sep-2021, PRODUCT DOSE OMISSION ISSUE (37 days since first dose, has not received 2nd yet) had resolved. At the time of the report, NASOPHARYNGITIS (Bad cold/really bad cold on his chest) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient had medicine for his heart as a concomitant.  Patient took cough medicine & antibiotics for treatment.  Patient had experienced the bad cold event just before 25th and which he still had for almost 3 weeks.   Most recent FOLLOW-UP information incorporated above includes: On 01-Nov-2021: Added batch number, concomitant and treatment information and event information.
Information ahs been received from an office manager concerning a 4 year old patient who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck) (lot number 656572/0115U). It was reported that after receiving the vaccine the patient developed varicella like lesions, less than 50 on the trunk and legs. A lot check has been initiated. Follow up information was received from a health professional requesting a lot check in varicella virus vaccine live (Oka/Merck) (lot number 656572/0115U). This is one report from the same source. Additional information has been requested.
I got my first COVID vaccine a day later my ear was stuffed I kept having people look in my ear no issues finally went to ent who diagnosed me with hearing loss. I have fullness and tinnitus in this right ear also
Fever, headache started on 4/1/13 at nite. Swelling - erythema to inj site. (L) upper arm. Cellulitis 3 cm diameter upper (L) arm.
Severe muscle joint pains/aches, chills and headache. Injection site pain unable to move arm without considerable pain.
Vaccine was bud of 10 weeks in the fridge at time of administration.  Vaccine expired 3/30/22.  Calling patient to advice re-vaccination per CDC guidelines.
Healthy with no former issues or drugs, non smoker. 1). Injection Immediate burn feel to area, then subsided  2). 11/27/21 right side chest and shoulder pain.   3). 12/2/21 Blood clot in both left and right lung
Within hours of the booster, I had fever and chills. This lasted for 3 days then I also had congestion, nausea, and headache for another 4 days. I tested positive for Covid on the 5th day after receiving the vaccine. I had been tested 3 days prior to the vaccine and was negative then.
Patient came into office with cellulitis on 7/29, area of reddness, warmth, tenderness, aprox 9 x 11 cm, no fever.
Pt c/o dizzy, light headed, diaphoretic and clammy. V/S obtained with b/p 132/68 HR 55 O2 99%. Pt was assissted to floor to prevent falling.  Given water and cool compress for neck.  Pt was held for 30  minutes after time. Pt refused EMS.  After time pt was released to go home.  A/Ox3.
Patient was administered a dose from an expired vial.; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial.) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Oct-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial.). On 18-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Patient was administered a dose from an expired vial.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.   This case was linked to MOD-2021-366918 (Patient Link).
h/a that started on 11AUG92 rt eye pressure radiating to temple; no visual problems; then exp whole body numbness which still exists; rt arm/leg, feet fatigued; no distinct weakness; poss neurologic (hypoesthesia) rxn to vax or migraine;
Allergic reaction manifested day following immunization of second dose in series. Itchy rash starting in lower extremities initially then manifested all over person. No other symptoms of an allergic reaction besides an itchy rash. Patient saw primary provider the day following immunization and received a prescription for triamcinolone 0.1% cream which provided minimal relief. She contacted the doctor 2 days following immunization and received a prescription for hydroxyzine 10 mg tablets BID.
This spontaneous case reported by a physician (subsequently medically confirmed), describes the occurrence of vaccination site pain (arm soreness - near injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 030L20A) for COVID-19 immunization. No medical history reported. On Jan 27, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Jan 28, 2021, patient experienced vaccination site pain (arm soreness - near injection site). At the time of the report, vaccination site pain (arm soreness - near injection site) outcome: unknown/not provided. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. The reporter did not provide any causality assessments, treatment information or concomitant medications